These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37579975)

  • 1. Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice.
    Younis MA; Sato Y; Elewa YHA; Harashima H
    J Control Release; 2023 Sep; 361():592-603. PubMed ID: 37579975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis.
    Younis MA; Sato Y; Elewa YHA; Kon Y; Harashima H
    J Control Release; 2023 Jan; 353():685-698. PubMed ID: 36521688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.
    Zhang C; Teng Y; Li F; Ho W; Bai X; Xu X; Zhang XQ
    ACS Nano; 2023 Aug; 17(15):14852-14870. PubMed ID: 37490628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo.
    Li Q; Ding Y; Guo X; Luo S; Zhuang H; Zhou J; Xu N; Yan Z
    J Cell Mol Med; 2019 Mar; 23(3):1951-1962. PubMed ID: 30592139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis.
    Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X
    Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases.
    Ezhilarasan D
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):315-322. PubMed ID: 33975780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells.
    Xia S; Liu Z; Cai J; Ren H; Li Q; Zhang H; Yue J; Zhou Q; Zhou T; Wang L; Liu X; Zhou X
    J Control Release; 2023 Mar; 355():54-67. PubMed ID: 36693527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
    Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
    Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
    Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
    Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.
    Birukawa NK; Murase K; Sato Y; Kosaka A; Yoneda A; Nishita H; Fujita R; Nishimura M; Ninomiya T; Kajiwara K; Miyazaki M; Nakashima Y; Ota S; Murakami Y; Tanaka Y; Minomi K; Tamura Y; Niitsu Y
    J Biol Chem; 2014 Jul; 289(29):20209-21. PubMed ID: 24867951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1.
    Jing F; Geng Y; Xu XY; Xu HY; Shi JS; Xu ZH
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-Based Silibinin Nanocrystals Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy.
    Luo S; Yang Y; Zhao T; Zhang R; Fang C; Li Y; Zhang Z; Gong T
    ACS Appl Mater Interfaces; 2023 Feb; 15(6):7747-7758. PubMed ID: 36719351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis.
    Radwan SAA; El-Maadawy WH; ElMeshad AN; Shoukri RA; Yousry C
    Pharm Res; 2020 Sep; 37(9):180. PubMed ID: 32875435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.
    Zhang J; Liu Y; Chen H; Yuan Q; Wang J; Niu M; Hou L; Gu J; Zhang J
    Cell Death Dis; 2022 Apr; 13(4):411. PubMed ID: 35484116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
    Oh Y; Park O; Swierczewska M; Hamilton JP; Park JS; Kim TH; Lim SM; Eom H; Jo DG; Lee CE; Kechrid R; Mastorakos P; Zhang C; Hahn SK; Jeon OC; Byun Y; Kim K; Hanes J; Lee KC; Pomper MG; Gao B; Lee S
    Hepatology; 2016 Jul; 64(1):209-23. PubMed ID: 26710118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
    Li Y; Zhang T; Zhang J; Liu Q; Jia Q; Chen W; Tang Q; Xiong Y; Xia Y; Xu Y; Mo L; Huang Y; He J
    Biomaterials; 2023 Oct; 301():122232. PubMed ID: 37418856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Delivery of Small Interfering RNA to Hepatic Stellate Cells Using a Lipid Nanoparticle Composed of a Vitamin A-Scaffold Lipid-Like Material.
    Toriyabe N; Sakurai Y; Kato A; Yamamoto S; Tange K; Nakai Y; Akita H; Harahsima H
    J Pharm Sci; 2017 Aug; 106(8):2046-2052. PubMed ID: 28456722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells.
    Bae M; Lee Y; Pham TX; Hu S; Park YK; Lee JY
    Life Sci; 2020 Sep; 256():117926. PubMed ID: 32535081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy.
    Wang K; Chen H; Qin S; Chen S; Zhang Q; Chen J; Di D; Su G; Yuan Y
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113567. PubMed ID: 37797465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.